• Facebook
  • Twitter
  • Youtube
  • Instagram
  • LinkedIn
  • Rss
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • The 1986 Club
    • Ways to Give
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Comprehensive Cancer Survivorship Act (CCSA)
    • Cancer Care Planning and Communications Act (CCPCA)
    • State of Survivorship Survey
      • 2022 Survey
      • 2021 Survey
      • 2020 Survey
    • Redefining Functional Status (RFS)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Advocate Engagement Opportunities
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Cancer Rehabilitation
    • Integrative Oncology
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Telehealth
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • 2023 Winners
      • Awardees
      • Reception and Sponsorship
      • Committees
      • Nominations
    • Cancer Policy Roundtable (CPR)
      • Spring 2023 CPR
      • Fall 2022 CPR
      • Spring 2022 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2022 State of Survivorship Survey Results
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Your generous year-end donation will be matched $1 for $1    DONATE

NCCS Issue Statement HHS CMS

NCCS Expresses Reservations Regarding Effectiveness and Impact of New CMS Drug Pricing Proposal

October 22, 2018/in Cancer News, Cancer Policy Blog Access to Care, Drug Pricing, Financial Toxicity, Health Equity Issue Statements, NCCS News
Shelley Fuld Nasso

By Shelley Fuld Nasso

NCCS Chief Executive Officer

October 22, 2018. – A focus of the National Coalition for Cancer Survivorship (NCCS) since it was founded over thirty years ago continues to be empowering patients to make informed decisions, and this includes transparency about the cost of health care.

The Centers for Medicare & Medicaid Services (CMS) recently proposed that list prices be included in direct-to-consumer (DTC) television advertisements of drugs that are reimbursed by Medicare and Medicaid. While we understand that CMS is taking small and concrete steps to advance its drug pricing agenda, we do not believe that the DTC proposal will achieve transparency, advance the effort to make Americans more informed health care consumers, or reduce drug prices. In fact, there is some concern that the proposal could harm patients and further complicate their decisions about care.

This proposal will affect only a portion of drugs—those that are advertised in television DTC ads—and will not even clearly affect prices for those drugs and is even less likely to affect those drugs not advertised in this manner.
First, the proposal to require list prices in certain DTC ads will provide cancer patients pricing information for only a portion of their care. Many drugs will not be subject to drug pricing transparency requirements because they are not advertised in DTC television ads. As a result, this proposal will not result in the provision of comprehensive information about cancer care costs to cancer patients. Cancer patients might have access to information about some of their drug costs and no information about others, as well as limited information about the cost of other elements of care. In addition, the proposal does not require that patients be provided the cost information that is most important to them, which is the information about what their treatment options will cost them in out-of-pocket spending. Neither does the proposal ensure communication about how their third-party insurance will cover their care. In short, this does not represent true transparency that is beneficial to patients and their decision-making process.

Second, cancer patients face difficult decisions from the time of diagnosis and in some circumstances they must make decisions under time pressure. Incorporating list prices of drugs into their decision-making would be a challenge even if they were provided comprehensive pricing information that can be compared. The CMS proposal falls far short of that standard and may instead create confusion and concern among cancer patients.

For example, NCCS believes that there is a risk that cancer patients may experience something akin to “sticker shock” if they see the prices of cancer drugs listed in DTC ads. The reaction to this sticker shock could be to forgo or delay care because of price concerns, even though the price in the DTC ad is not the cost that the patient may bear.

Although CMS suggests that it might consider a new budget-neutral payment code for doctors to speak with patients on the benefits of drugs and drug alternatives, we are not persuaded that this effort—even if it is pursued by CMS—would be sufficient to ensure informed decision-making by patients. NCCS and its colleagues in the cancer community strongly advocate the establishment of a cancer care planning service that would permit consideration of treatment options, the review of treatment side-effects and long-term treatment management, and the cost of care (including prices of treatments and relevant patient cost-sharing responsibilities). The care planning service we envision is comparable to the service that is provided to patients through the Oncology Care Model demonstration project and is a more comprehensive service than is mentioned in the current proposal.

Finally, the proposal to list prices in DTC ads is intended to reduce drug prices. We are not persuaded that the listing of prices in DTC ads will in fact reduce the price of drugs at time of market introduction or the possibility of price increases after market entry. This proposal will affect only a portion of drugs—those that are advertised in television DTC ads—and will not even clearly affect prices for those drugs and is even less likely to affect those drugs not advertised in this manner. Because the proposal may fail to achieve its fundamental goal and creates additional problems for patients, we cannot lend our support to it.

We are also concerned that the DTC ad proposal will deflect attention from efforts that might be more effective in protecting patient access to affordable medications and in empowering patients to choose treatments on the basis of effectiveness, impact on quality of life, and cost to them and the health care system. Comprehensive, out-of-pocket cost information that patients can use to compare treatments and costs would be a much more significant step forward to achieving actual transparency than the current CMS proposal.

https://canceradvocacy.org/blog/health-care-roundup-oct-19-2018/
https://canceradvocacy.org/policy-comments/nccs-joins-clc-concerns-hhs-step-therapy-plan/

Tags: cancer care, Cancer Survivorship, CMS, drug pricing, financial issues, HHS, issue statement, price transparency
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
https://canceradvocacy.org/wp-content/uploads/2018/10/NCCS-Issue-Statement-HHS-CMS.jpg 600 1200 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2018-10-22 10:23:062020-07-06 10:05:21NCCS Expresses Reservations Regarding Effectiveness and Impact of New CMS Drug Pricing Proposal

Latest News

Brett Wilson – Navigating Childhood Cancer and Finding Purpose in Advocacy

September 13, 2023
Advocate Spotlight: Brett Wilson Brett Wilson's cancer experience started when she was just two years old. Her mother was concerned…
Read more
https://canceradvocacy.org/wp-content/uploads/Brett-Wilson-Advocate-Spotlight-Blog-Banner.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2023-09-13 13:55:422023-09-13 14:29:44Brett Wilson – Navigating Childhood Cancer and Finding Purpose in Advocacy

Registration Open: 2023 State of Survivorship Survey Results Briefing | October 3

September 7, 2023
The National Coalition for Cancer Survivorship (NCCS) conducts an annual State of Survivorship Survey, in partnership with Edge…
Read more
https://canceradvocacy.org/wp-content/uploads/Survey-2023-briefing-mc-1200px-2-1.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2023-09-07 11:00:202023-09-07 11:00:20Registration Open: 2023 State of Survivorship Survey Results Briefing | October 3
We did it! DIEP Flap Codes Saved

CMS Announces It Will Retain Breast Reconstruction Codes, A Reversal That Protects Patient Access to DIEP Flap Surgery

August 22, 2023
Yesterday, the Centers for Medicare and Medicaid Services (CMS) announced that it will retain procedure codes for breast cancer reconstruction,…
Read more
https://canceradvocacy.org/wp-content/uploads/DIEP-Flap-Reconstruction-CMS-Codes.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2023-08-22 14:26:202023-08-22 14:26:20CMS Announces It Will Retain Breast Reconstruction Codes, A Reversal That Protects Patient Access to DIEP Flap Surgery

Take Action

Link to: Survivorship Champions

Become a Survivorship Champion

Survivorship Champions is a program for all clinicians and researchers, both oncology and primary care, who are interested in improving survivorship care and primary care’s role in caring for cancer survivors.

Learn More and Join »
Link to: Cancer Policy and Advocacy Team (CPAT)

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Learn More and Join »
Link to: Survivor Stories

Share Your Story

NCCS represents the millions of Americans who share a common experience – living with, through and beyond a cancer diagnosis. By sharing your story of how you have been touched by cancer, you are supporting the national cancer survivorship movement.

Share Your Story »

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • This field is for validation purposes and should be left unchanged.

  • About
    • Our Mission
    • Our History
    • The 1986 Club
    • Ways to Give
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Comprehensive Cancer Survivorship Act (CCSA)
    • Cancer Care Planning and Communications Act (CCPCA)
    • State of Survivorship Survey
      • 2022 Survey
      • 2021 Survey
      • 2020 Survey
    • Redefining Functional Status (RFS)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Advocate Engagement Opportunities
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Cancer Rehabilitation
    • Integrative Oncology
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Telehealth
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • 2023 Winners
      • Awardees
      • Reception and Sponsorship
      • Committees
      • Nominations
    • Cancer Policy Roundtable (CPR)
      • Spring 2023 CPR
      • Fall 2022 CPR
      • Spring 2022 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2022 State of Survivorship Survey Results
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2023 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

Health Care Roundup: Drug Pricing in TV Ads; Even with Insurance, Serious Illness...NCCS Starburst 250pxNCCS Blog CPM LogoNCCS Concerned About New CMS Guidance on 1332 Waiver Process
Scroll to top
Download the Survey Report

"*" indicates required fields

Fill out the form below, and we’ll send the survey report, detailed presentation, and infographic to your email.
Name*
I am a...*
Select any/all that apply.
Consent*
By downloading the survey materials, you will receive updates and information from NCCS via email, which you may unsubscribe from at any time. Your information will never be sold to any third parties.
This field is for validation purposes and should be left unchanged.

Get Updates From NCCS

Be the first to hear about cancer policy and survivorship issues! Subscribe and receive the biweekly NCCS Health Care Roundup, invites to webinars and events, and more.

  • This field is for validation purposes and should be left unchanged.

Connect With Us

Twitter     Facebook     Instagram     LinkedIn     YouTube

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute